COMMUNIQUÉS West-GlobeNewswire

NewGenIvf Provides Update on Potential Reverse Merger with COVIRIX
23/07/2024
BANGKOK, July 24, 2024 (GLOBE NEWSWIRE) -- NewGenIvf Group (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility [...]
Pennant Announces Second Quarter 2024 Earnings Release and Call
23/07/2024
EAGLE, Idaho, July 23, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it [...]
Kronos Bio Announces First Patient Dosed with KB-0742 in an Expansion Cohort Focused on Platinum-Resistant High-Grade Serous Ovarian Cancer
23/07/2024
— KB-0742 cleared 80mg four-days-on, three-days-off dosing schedule in dose escalation — — Company expects to provide an efficacy update on this expansion cohort in 1H 2025 — SAN MATEO, Calif. and CAMBRIDGE, Mass., July [...]
Supernus Pharmaceuticals to Announce Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024
23/07/2024
ROCKVILLE, Md., July 23, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
NeuroPace to Report Second Quarter 2024 Financial Results on August 13, 2024
23/07/2024
MOUNTAIN VIEW, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will report [...]
The Ensign Group Schedules Second Quarter Earnings Call for Friday, July 26, 2024
23/07/2024
SAN JUAN CAPISTRANO, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
Lumos Pharma to Report Second Quarter 2024 Financial Results and Provide Clinical Update on August 1, 2024
23/07/2024
AUSTIN, Texas, July 23, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a late-stage biopharmaceutical company focused on therapeutics for rare diseases, announced it will report second quarter 2024 financial [...]
Beyond Air® to Report First Fiscal Quarter 2025 Financial Results on August 6
23/07/2024
GARDEN CITY, N.Y., July 23, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of [...]
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
23/07/2024
LEXINGTON, Mass., July 23, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, has entered into an employment agreement with Eric [...]
Progyny, Inc. Announces Details for Its Second Quarter 2024 Results Report
23/07/2024
NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the quarterly period [...]
NADP Revitalizes its Foundation
23/07/2024
Organization’s mission is to improve oral health through research and education DALLAS, July 23, 2024 (GLOBE NEWSWIRE) -- The National Association of Dental Plans (NADP) recently revitalized its independent Foundation [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 29 - 2024
23/07/2024
Aggregated presentation by day and by market Purchases of own shares from July 15th to 19th, 2024 Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 29 - 2024
23/07/2024
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 15 au 19 juillet 2024 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 juin 2024
23/07/2024
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 juin 2024 En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, les [...]
Pro League Network teams up with Birches Health on Responsible Gaming & Problem Gambling initiatives
23/07/2024
NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Pro League Network (PLN), the leading sports media and entertainment company producing sports purpose-built for a wagering audience and short form consumption has struck a [...]
Acentra Health Names Brett Barton as Senior Vice President of Client Experience
23/07/2024
MCLEAN, Va., July 23, 2024 (GLOBE NEWSWIRE) -- Acentra Health , a technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, has named Brett [...]
Leviton Canada donates $100,000 to the Lachine Hospital Foundation to expand services and care in the West Island
23/07/2024
Leviton Canada’s gift supports the ongoing revitalization project at Lachine Hospital and the purchase of lifesaving equipment. MONTREAL, July 23, 2024 (GLOBE NEWSWIRE) -- A new $100,000 donation from Leviton Canada is [...]
Leviton Canada fait un don de 100 000 $ à la Fondation de l’Hôpital de Lachine pour améliorer les services et les soins dans l’Ouest-de-l’Île
23/07/2024
Le don de Leviton Canada soutient le projet de revitalisation en cours à l’Hôpital de Lachine et l’achat d’équipement qui sauvera des vies. MONTRÉAL, 23 juill. 2024 (GLOBE NEWSWIRE) -- Leviton Canada fait un don de 100 [...]
Virios Therapeutics Announces Completion of Enrollment in IMC-2 Phase 2 Long-COVID Study Being Conducted by Bateman Horne Center
23/07/2024
- Virios projects releasing top line results from this groundbreaking Proof of Concept study in October 2024 - - Published data indicates increased Epstein-Barr herpes virus in Long-COVID patients, highlighting [...]

Pages